GMP Auditing & Consulting LLC — Reference Docket

21 CFR & GMP Regulatory Index

Regulations, FDA/ICH guidances, and inspection compliance program manuals, organized by product category — every entry links to its source. Search by keyword or citation.

— entries indexed Updated for QMSR (eff. 2/2/2026)

Overall Index

No entries match that search.

A GMP Auditing & Consulting LLC resource.

This library maps FDA drug, biologic, and device requirements to the product categories our clients actually build against — active pharmaceutical ingredients, sterile and non-sterile drug manufacturing, cosmetics, biologics (vaccines, cell and gene therapy, blood and plasma products, therapeutic proteins), and medical devices across all three risk classes. It reflects FDA's February 2026 transition from the Quality System Regulation to the Quality Management System Regulation (QMSR). Every citation links to its official source — eCFR.gov, FDA.gov, or ICH.org. Regulatory guidance is revised on an ongoing basis; we review this library periodically and welcome corrections at gmpauditingandconsultingllc@gmail.com. This index is a navigational aid, not legal or regulatory advice.